PYRROLO [2, 3 -D]PYRIMIDINE DERIVATIVES AS INHIBITORS OF JANUS- RELATED KINASES (JAK)

Described herein are pyrrolo{2,3-d}pyrimidine derivatives, their use as Janus Kinase (JAK) inhibitors, and pharmaceutical compositions containing them.

Saved in:
Bibliographic Details
Main Authors FLANAGAN, Mark Edward, TRZUPEK, John David, MITTON-FRY, Mark. J, STROHBACH, Joseph Walter, TENBRINK, Ruth E, JOHNSON, Timothy Allan, PARIKH, Mihir D, KAILA, Neelu, VAZQUEZ, Michael L, UNWALLA, Rayomand Jal, GONZALES, Andrea, BROWN, Matthew Frank, FENWICK, Ashley Edward
Format Patent
LanguageEnglish
Published 27.07.2016
Online AccessGet full text

Cover

Abstract Described herein are pyrrolo{2,3-d}pyrimidine derivatives, their use as Janus Kinase (JAK) inhibitors, and pharmaceutical compositions containing them.
AbstractList Described herein are pyrrolo{2,3-d}pyrimidine derivatives, their use as Janus Kinase (JAK) inhibitors, and pharmaceutical compositions containing them.
Author VAZQUEZ, Michael L
JOHNSON, Timothy Allan
STROHBACH, Joseph Walter
KAILA, Neelu
TRZUPEK, John David
PARIKH, Mihir D
FENWICK, Ashley Edward
BROWN, Matthew Frank
GONZALES, Andrea
FLANAGAN, Mark Edward
UNWALLA, Rayomand Jal
MITTON-FRY, Mark. J
TENBRINK, Ruth E
Author_xml – fullname: FLANAGAN, Mark Edward
– fullname: TRZUPEK, John David
– fullname: MITTON-FRY, Mark. J
– fullname: STROHBACH, Joseph Walter
– fullname: TENBRINK, Ruth E
– fullname: JOHNSON, Timothy Allan
– fullname: PARIKH, Mihir D
– fullname: KAILA, Neelu
– fullname: VAZQUEZ, Michael L
– fullname: UNWALLA, Rayomand Jal
– fullname: GONZALES, Andrea
– fullname: BROWN, Matthew Frank
– fullname: FENWICK, Ashley Edward
BookMark eNrjYmDJy89L5WQIDYgMCvL38VeINtJRMFbQdYkFCnj6erp4-rkquLgGeYY5hniGuQYrOAYrePp5eDp5hvgHBSv4uyl4OfqFBusqBLn6OIa4uih4e_o5BgPVaXg5emvyMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLE5NS81JL4KEcjA0NTA1MTUxMnY2LUAABZ3jGd
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID ZA201505454B
GroupedDBID EVB
ID FETCH-epo_espacenet_ZA201505454B3
IEDL.DBID EVB
IngestDate Fri Oct 18 06:02:16 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_ZA201505454B3
Notes Application Number: ZA20150005454
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160727&DB=EPODOC&CC=ZA&NR=201505454B
ParticipantIDs epo_espacenet_ZA201505454B
PublicationCentury 2000
PublicationDate 20160727
PublicationDateYYYYMMDD 2016-07-27
PublicationDate_xml – month: 07
  year: 2016
  text: 20160727
  day: 27
PublicationDecade 2010
PublicationYear 2016
RelatedCompanies Pfizer Inc
RelatedCompanies_xml – name: Pfizer Inc
Score 3.0439644
Snippet Described herein are pyrrolo{2,3-d}pyrimidine derivatives, their use as Janus Kinase (JAK) inhibitors, and pharmaceutical compositions containing them.
SourceID epo
SourceType Open Access Repository
Title PYRROLO [2, 3 -D]PYRIMIDINE DERIVATIVES AS INHIBITORS OF JANUS- RELATED KINASES (JAK)
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160727&DB=EPODOC&locale=&CC=ZA&NR=201505454B
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFfWmVdH6YAUJCgZtsumeimxeNNUmJUlLrUjJE_SQFhvx7zsbWutFb8ssDLsD89ydbwCucoUmLSVN5ExNMEGJMIaLI9aWozRu5VRliVbhzPbddndIe2NtXIP3VS9MhRP6VYEjokYlqO9lZa_n6yKWWf2tXNzFb0iaPdhhx5SW2bFAS1OYZOoda-CZniEZRmfCJdcXe-jrqUb1DdjEMJoJbbBGuuhKmf92KfYebA2QW1HuQy0rGrBjrCavNWC7v3zwxuVS9xYHMBw8-7735JEX5ZaoRDZfkYCmx3Rci5iYj4146IysgPCAOG7X0Z3Q8wPi2aTH3WEgEzEdA-0UwYSdoxUl1z3-eHMIl7YVGl0Zzzf9EcZ0wtdXUY-gXsyK7BiIlkU5Zewe462EtjBwSlUWxVGS5lHcjhk9gebffJr_bZ7CrhCsqGcq7Azq5cdndo6OuIwvKgl-A82lhVg
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZS8NAEB5qFeubVkXrtYIEBYM22XSfiuQk6ZGUJC21IiEn6ENabMS_7yS01hd9W2Zh2B2Yc3e-AbjJBBq3hSTmUzHGBCXEGC4KWYcPk6idUZHFUoUzO7Q75pj2ptK0Bu_rXpgKJ_SrAkdEjYpR34vKXi82RSyt-lu5fIjekDR_Mvyuxq2y4xItTWCcpnT1kaM5Kqeq3ZnM2W65h76eSlTZgm0MsVmpDfpEKbtSFr9dirEPOyPklhcHUEvzJjTU9eS1JuwOVw_euFzp3vIQxqNn13UGDnkR7olIeO0VCWh6NMvWiYb52ET2rYnuEdkjlm1aiuU7rkccg_Rke-zxpJyOgXaKYMIuoxUltz25f3cE14buqyaP5wt-hBHM5M1VxGOo5_M8PQEipWFGGXvEeCumbQycEpGFURgnWRh1IkZPofU3n9Z_m1fQMP3hIBhYdv8M9kohl7VNgZ1Dvfj4TC_QKRfRZSXNbzqiiEs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PYRROLO+%5B2%2C+3+-D%5DPYRIMIDINE+DERIVATIVES+AS+INHIBITORS+OF+JANUS-+RELATED+KINASES+%28JAK%29&rft.inventor=FLANAGAN%2C+Mark+Edward&rft.inventor=TRZUPEK%2C+John+David&rft.inventor=MITTON-FRY%2C+Mark.+J&rft.inventor=STROHBACH%2C+Joseph+Walter&rft.inventor=TENBRINK%2C+Ruth+E&rft.inventor=JOHNSON%2C+Timothy+Allan&rft.inventor=PARIKH%2C+Mihir+D&rft.inventor=KAILA%2C+Neelu&rft.inventor=VAZQUEZ%2C+Michael+L&rft.inventor=UNWALLA%2C+Rayomand+Jal&rft.inventor=GONZALES%2C+Andrea&rft.inventor=BROWN%2C+Matthew+Frank&rft.inventor=FENWICK%2C+Ashley+Edward&rft.date=2016-07-27&rft.externalDBID=B&rft.externalDocID=ZA201505454B